Combining Multidrug-Resistant Bacteria Using Chemokine-Derived Antimicrobial Peptides. Inventors: Molly Hughes, Borna Mehrad
|
|
- Claude Basil Gaines
- 5 years ago
- Views:
Transcription
1 Combining Multidrug-Resistant Bacteria Using Chemokine-Derived Antimicrobial Peptides Inventors: Molly Hughes, Borna Mehrad
2 Clinical Value: Antibiotic Resistance is an Urgent Global Health Concern and New Antibiotic Strategies are Critically Needed Clinical importance and market value: -In U.S., >2 million infections due to MDR organisms with ~23,000 deaths per year. -Worldwide, >700,000 deaths/year due to MDR bacterial infections. If left unchecked, it is estimated that by 2050, ~10 million deaths/year with reduction in world s GDP by trillions of dollars annually due to MDR infections Urgent campaigns Problematic bacteria for drug resistance identified as ESKAPE pathogens: Lack of new antibiotics in the drug discovery pipeline Enterococcus faecium Staphylococcus aureus Klebsiella pneumoniae Acinetobacter baumannii Pseudomonas aeruginosa 2 Enterobacter spp. CXCL10-derived peptides kill ESKAPE pathogens and MDR Superbugs
3 Project Background Information: CXC Chemokine CXCL10 as Novel Antimicrobial Agent Very potent at recruiting immune cells to sites of inflammation via interaction with its human receptor CXCR3 Direct antimicrobial activity against variety of bacteria (Yang et al. and other groups) CXCR3 receptor interaction responsible for chemotaxis Resemblance to antimicrobial peptides (cationic, amphipathic helix) Adapted from: Frederick, Expert Rev. Mol. Med., 3(19):1-18; 2001 Team members: Dr. Hughes and Dr. Mehrad = collaborators for 12 years on CXC chemokine antimicrobial activity (Hughes) and host immune response / in vivo models of infection (Mehrad) 3
4 CXCL10 kills MDR Gram-negative clinical isolates MDR Acinetobacter baumannii clinical isolate Untreated control CXCL10 treatment Survival of MDR bacteria following exposure to recombinant CXCL10 or buffer alone. Viability was measured by CFU determination, as demonstrated. 4
5 CXCL10 peptide library screen: N- and C-terminal peptides have antibacterial activity against multidrug resistant (MDR) bacteria VPLSRTVRCT CISISNQPVN PRSLEKLEII PASQFCPRVE IIATMKKKGE KRCLNPESKA IKNLLKAVSK ERSKRSP Peptide 1 and its variants = antibacterial activity +/- chemotactic (immunostimulatory) Peptide 9 and its variants = antibacterial activity with no chemotactic activity Goal is to optimize these immunomodulatory antimicrobial peptides for customized applications Killer experiment = Test efficacy of optimized leading candidate peptides in an in vivo infection model (murine wound infection model or murine pneumonia model) 5
6 Peptide antimicrobial activity against multidrug-resistant bacteria % survival (log 10 ) E. faecium ** S. aureus K. pneumoniae nd A. baumannii P. aeruginosa E. cloacae N. gonorrhoeae S.Typhi S. flexneri peptide: P1 P5 P9 6 Main take-home points: Peptide 1: antimicrobial activity against Gram-positive and Gram-negative organisms Peptide 5: negative control (no antimicrobial activity) Peptide 9: antimicrobial activity against many Gram-negative organisms, no Gram-positive activity
7 Antimicrobial activity of CXCL10-derived peptides CXCL10-derived peptides were tested for bactericidal activity against Gram-negative and Gram-positive organisms (Y=antimicrobial activity (85-95% killing), N=no antimicrobial activity). Peptide 1 exerted broad-spectrum bactericidal activity against all organisms and Peptide 9 was effective at killing Gram-negative bacteria. 57
8 Alanine Scan of Peptide 1 Reveals Key Amino Acids in Sequence: CRE K. pneumoniae data P1: VPLSRTVRCTCISI APLSRTVRCTCISI VALSRTVRCTCISI VPASRTVRCTCISI VPLARTVRCTCISI VPLSRAVRCTCISI VPLSRTARCTCISI VPLSRTVACTCISI VPLSRTVRATCISI VPLSRTVRCACISI VPLSRTVRCTAISI VPLSRTVRCTCASI VPLSRTVRCTCIAI VPLSRTVRCTCISA P5: EIITMKKKGEKRCL <---VPLSATVRCTCISI not yet synthesized K. pneumoniae AKU % BL13802 Control, fluorescence (NDM1 CRE) Survival as % of Control 100
9 Minimal length of Peptide 1 derivative determined to be 8 amino acids CRE Klebsiella pneumoniae P5: EIIATMKKKGEKRCL P1: VPLSRTVRCTCISI P60: RTVRCTCI Peptide concentration [5.6 µm] n = 2 experiments P65: RTVRCTC P66: RTVCRTCI (SCRAMBLED) P67: RVCTICRT (SCRAMBLED) Survival as % Control, fluorescence 160 9
10 % Control, Fluorescence K. pneumoniae AKU BL13802 (NDM1 CRE) Survival, % Control Chimeric Peptide P1-GGG-P9 Kills Klebsiella pneumoniae CRE Isolate P55 (P1-GGG-P9): VPLSRTVRCTCISIGGGPESKAIKNLLKAVSKERSKRSP P1 P55 P5 mm 10
11 Antimicrobial activity in traditional low salt hypotonic buffer versus RPMI tissue culture medium 10mM KPB/1%TSB hypotonic buffer RPMI tissue culture medium, buffered with HEPES Survival as % Control P1 P9 P1 + P9 P1-GGG-P9 P9-GGG-P1 Peptide 9 loses activity in RPMI (it only has activity in hypotonic buffer) Peptide 1 retains activity in RPMI but has solubility issues at higher concentrations Chimeric peptides retain activity in RPMI; no solubility issues noted so far Chimeric peptides are more effective than just Peptide 1 and Peptide 9 added to same well P5 Peptide concentration [mm] 11
12 Initial toxicity studies: Human red blood cell (RBC) hemolysis assay Melittin (bee venom) and Triton X-100 (detergent): positive controls for RBC hemolysis the negative controls 12
13 Summary of peptide antibacterial activity data P1 exhibits bacterial killing activity in RPMI tissue culture medium, but its use at higher concentrations is limited by solubility issues P9 exhibits bacterial killing only in hypotonic, low salt buffer; activity abolished in medium with physiological salt concentrations P1 and P9, when added separately into the same wells, do not exhibit the same potency as the conjugate peptides Conjugate peptides: P1-GGG-P9 and P9-GGG-P1 each exhibit antimicrobial activity in RPMI tissue culture medium with physiological salt concentrations; no solubility issues so far Shortest P1-derived peptide that retains activity is 8 amino acids: RTVRCTCI (includes core amino acids determined by the alanine scan) 13 Initial toxicity testing promising: <4% hemolysis of human red blood cells
14 Relevant Publications PNAS Oct 11;108(41) Hughes MA, et. al. PLoS Pathogens Nov;6(11)e Hughes MA, et. al. Infect Immun Apr;77(4) Hughes MA, et. al. Relevant IP U.S. Provisional Application 62/702,557 filed 7/24/18 U.S. Provisional Application 62/743,662 filed 10/10/18 614
Peptide deformylase from superbacteria
Peptide deformylase from superbacteria Antibiotics Most antibiotics were originally isolated from soil-derived actinomycetes between 1940s and 1960s (Golden era of antibiotic discovery) Natural product
More informationCloudbreak: Antibody-Drug Conjugates for Treatment of MDR Gram-Negative Bacterial Infections
Cloudbreak: Antibody-Drug Conjugates for Treatment of MDR Gram-Negative Bacterial Infections James C. Levin, Ph.D. Director of Preclinical Development Discovery on Target Conference September 26, 2018
More informationRenaissance of the Goldstandard
Renaissance of the Goldstandard (?) Fluorogenic Enzyme Substrates in the Detection and Identification of Bacteria Linda Varadi CSIRO Manufacturing linda.varadi@csiro.au Contact Prof Paul Groundwater Faculty
More informationBacteriophage Therapeutics for Patients with Antibiotic-Resistant Infections
Bacteriophage Therapeutics for Patients with Antibiotic-Resistant Infections November 7, 2017 NYSE MKT: APHB Safe Harbor Statement This presentation contains forward-looking statements that involve risks,
More informationElena BM Breidenstein, PhD 21 April 2018
Discovery of a Novel Oral Antibiotic, DDS-01 (SMT-571), to Treat Multi-Drug Resistant Neisseria gonorrhoeae Enabled by a Proprietary Transposon Technology Elena BM Breidenstein, PhD 21 April 2018 Forward-Looking
More informationStrategies to Combat Bacterial Resistance: Towards Development of Future Antibacterial Drugs
Strategies to Combat Bacterial Resistance: Towards Development of Future Antibacterial Drugs Dr. Jayanta Haldar, PhD Assistant Professor New Chemistry Unit Jawaharlal Nehru Centre for Advanced Scientific
More informationAntibiotic Resistance Genes: From The Farm To The Human Gut
Shanghai 2015 Antibiotic Resistance Genes: From The Farm To The Human Gut Baoli Zhu, PhD Institute of Microbiology, Chinese Academy Beijing Key Lab of Microbial Drug Resistance and Resistome zhubaoli@im.ac.cn
More informationUnderstanding the Development Challenges Associated with Emerging Non-Traditional Antibiotics
Understanding the Development Challenges Associated with Emerging Non-Traditional Antibiotics JW Marriott Washington, DC June 14, 2018 Discussion Guide Introduction Antimicrobial resistance (AMR) is a
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AWARD NUMBER: W81XWH-15-1-616 TITLE: Evaluation of Novel Antimicrobial Peptides as Topical Anti-Infectives with Broad Spectrum Activity Against Combat- Related Bacterial and Fungal Wound Infections PRINCIPAL
More informationBiofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement
Biofilm Protocol Optimization For Pseudomonas aeruginosa Culture Media, Incubation Time, and Biofilm Measurement Introduction In addition to the conventional arsenal of antibiotic resistance mechanisms
More informationFACTSHEET. Introduction. Antibodies ALTERNATIVES TO ANTIBIOTICS
FACTSHEET ALTERNATIVES TO ANTIBIOTICS Introduction Due to antibiotic resistance and the long-term lack of antibiotic discovery, alternative treatments and effective prevention strategies for bacterial
More informationAntibiotics and alternative strategies to control infections
Antibiotics and alternative strategies to control infections http://blog.microbiologics.com/wpcontent/uploads/2015/12/acinetob acter-baumannii-232x300.jpg www.biochemj.org/bj/330/0581/bj3300581.htm ciss.blog.olemiss.edu
More informationAdvancing bacteriophage therapeutics for patients with antibioticresistant. Company Overview. May 15, 2018 NYSE American: APHB
Advancing bacteriophage therapeutics for patients with antibioticresistant infections Company Overview May 15, 2018 NYSE American: APHB Safe Harbor Statement This presentation contains forward-looking
More informationJanuary 2018 ASX: RCE. Recce Pharmaceuticals Ltd
January 2018 ASX: RCE Recce Pharmaceuticals Ltd Tackling Superbugs RECCE 327 1 Corporate summary Commercialising promising new class of synthetic antibiotics Focus is new treatments for drug resistant
More informationIndigo-Clean White Paper: #1 Bactericidal Performance Testing of Indigo-Clean Upon Bacterial Species. Healthcare
Indigo-Clean White Paper: #1 Bactericidal Performance Testing of Indigo-Clean Upon Bacterial Species Healthcare HC Bactericidal Performance Testing of Indigo-Clean Upon Bacterial Species Clifford J. Yahnke,
More informationAntimicrobial Resistance Prediction Using Deep Convolutional Neural Networks on Whole Genome Sequencing Data
Antimicrobial Resistance Prediction Using Deep Convolutional Neural Networks on Whole Genome Sequencing Data PRIMES Research Report by: Andrew Zhang Mentor: Dr. Gil Alterovitz PRIMES Conference October
More informationAntimicrobial Peptides
Antimicrobial Peptides 1 / 6 2 / 6 3 / 6 Antimicrobial Peptides 17 Prediction and Rational Design of Antimicrobial Peptides William F. Porto, Osmar N. Silva and Octávio L. Franco Universidade Católica
More informationEnvironmental Surveillance FIDSSA Dr Ben Prinsloo Medical Microbiologist
Environmental Surveillance FIDSSA 2015 Dr Ben Prinsloo Medical Microbiologist The Scientist A scientist, in a broad sense, is a person engaging in a systematic activity to acquire knowledge We require
More informationDeveloping Bacteriophage Therapies for Patients with Antibiotic-Resistant Infections
Developing Bacteriophage Therapies for Patients with Antibiotic-Resistant Infections 2017 BIO International Convention June 21, 2017 NYSE MKT: APHB Safe Harbor Statement This presentation contains forward-looking
More informationCARB-X Funding Rounds for 2018 Supporting innovation to fight drug-resistant bacteria. Kevin Outterson 12 March 2018
CARB-X Funding Rounds for 2018 Supporting innovation to fight drug-resistant bacteria Kevin Outterson 12 March 2018 2 A non-profit partnership accelerating the best science from around the world to fight
More informationENABLE (IMI) presentation of activities
ENABLE (IMI) presentation of activities A European antibacterial drug discovery platform Anders Karlén Uppsala University (SE) New Drugs for Bad Bugs (ND4BB) Structure ND4BB Co-ordination team (science
More informationNIMBUS The Next Generation in Antimicrobial Protection. October, 2010
NIMBUS The Next Generation in Antimicrobial Protection October, 2010 What is NIMBUS? NIMBUS represents a breakthrough in antimicrobial technology for wound care and other medical device applications No
More informationJOHN DEMPSEY HOSPITAL Farmington, Connecticut ANTIBIOTIC SUSCEPTIBILITY PROFILES for INPATIENT Bacterial Isolates
JOHN DEMPSEY HOSPITAL Farmington, Connecticut 2017 ANTIBIOTIC SUSCEPTIBILITY PROFILES for INPATIENT Bacterial Isolates **GROUPED BY CULTURE SOURCES** (data from 1/1/17 1/1/18) Prepared by: UCHC/JDH Antimicrobial
More informationSonoSteam. Hanieh Musavian, SonoSteam FORCE Technology. Teknologi der kun anvender damp-ultralyd, derfor ingen kemi.
SonoSteam Hanieh Musavian, SonoSteam, FORCE Technology SonoSteam FORCE Technology Teknologi der kun anvender damp-ultralyd, derfor ingen kemi. Force Technology SonoSteam SonoSteam is a division within
More information1 Publishable Summary
1 Publishable Summary Project context and objectives Antimicrobial resistance (AMR) is a global public health concern and the EU Commission considers the development of new effective antimicrobials or
More informationSlide title. Deborah O NeilO. February 23 rd, t: f:
Deborah O NeilO February 23 rd, 2011 The Business Based in Aberdeen Key biologics & anti-infectives infectives cluster Founded 2004 Design & develop novel anti-infectives infectives Peptide therapeutics
More informationNEW DRUGS FOR BAD BUGS The Innovative Medicines Initiative response to antimicrobial resistance
NEW DRUGS FOR BAD BUGS The Innovative Medicines Initiative response to antimicrobial resistance Scan this QR code to download this booklet: IMI 2 Joint Undertaking, 2017 Photographs: Shutterstock, 2014
More informationONAMER M. PRESERVATIVE and ANTIMICROBIAL ONAMER
ONAMER M PRESERVATIVE and ANTIMICROBIAL ONAMER M Stepan Lipid Nutrition is a division of Stepan Company which manufactures lipid and polymer based ingredients. HO OH SUMMARY Our quaternary ammonium polymer
More informationProtocols for Laboratory Verification of Performance of the BioFire FilmArray Blood Culture Identification (BCID) Panel
Protocols for Laboratory Verification of Performance of the BioFire FilmArray Blood Culture Identification (BCID) Panel Laboratory Protocols for Use with Microbiologics Helix Elite Molecular Standards
More informationAN TB IOTIC. This project is funded by the European Union. This project is funded by the European Union.
TUBERCULOSIS Tuberculosis () today rivals HIV/AIDS as the leading cause of death from infectious diseases. The number of patients has never been higher than today and the growing proportion of drug-resistant
More informationCurriculum Vitae. Abbas Maleki, Ph.D. Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran
Curriculum Vitae Abbas Maleki, Ph.D Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran E-mail: abbasmaleki_ilam@yahoo.com maleki-a@medilam.ac.ir Tel: +989187419401 Personal
More informationANTI-BACTERIAL EXECUTIVE SUMMARY
ANTI-BACTERIAL EXECUTIVE SUMMARY All antibacterial test results were conducted using the AATCC Method 100 standard testing protocol for textiles. All testing showed consistent performance for both gram
More informationStudy Title Antibacterial Efficacy of Bio-Care Technology's Non-Porous Test Substance
Study Title Antibacterial Efficacy of Bio-Care Technology's Non-Porous Test Substance Test Method Japanese Industrial Standard Z 2801 Antibacterial Products Test for Antibacterial Activity and Efficacy
More informationPhotodynamic inactivation of multidrug resistant pathogens in Hong Kong
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES CMN Yow 邱李妙顏 K Fung 馮秀珍 KC Wong 黃建忠 Key Messages 1. Photodynamic therapy could be an alternative treatment for highly prevalent local antibiotic-resistant
More information1 Publishable Summary
1 Publishable Summary Project context and objectives Antimicrobial resistance (AMR) is a global public health concern and the EU Commission considers the development of new effective antimicrobials or
More informationAntibiotics to Treat Multidrug-Resistant Bacterial Infections
Antibiotics to Treat Multidrug-Resistant Bacterial Infections Copyright 2017 Tetraphase Pharmaceuticals, Inc. C O M P A N Y P R E S E N T A T I O N A p r i l 2 0 1 7 TTPH Forward-Looking Statements and
More informationand Product Protection Process
UniFirst Garment Service for Healthcare UniFirst Garment Service for Healthcare and Product Protection Process Workwear Solutions for Healthcare Industry Safety A laboratory study to measure the effectiveness
More informationAntimicrobial Drugs. Antimicrobial Drugs. The dawn of antibiotics. Alexander Fleming. Chain and Florey. Antibiotics
Antimicrobial Drugs Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease Antimicrobial drugs: Interfere with the growth of microbes within a host Antibiotic: Substance produced by a microbe
More informationAthanassios Tsakris Medical School, University of Athens Greece
Athanassios Tsakris Medical School, University of Athens Greece Each hour of delay (over the first 6 hours) resulting in a 7.6% decrease in survival «In septic shock, time is life» Kumar A, Crit Care Med
More informationThe ENABLE project: An antibiotic discovery platform
The ENABLE project: An antibiotic discovery platform Anders Karlén Putting open innovation into practice case studies from Europe 23.05.2017 PSWC Stockholm, Sweden The rising threat of antimicrobial resistance
More informationSupplemental Information:
Supplemental Information: Detection of ESKAPE bacterial pathogens at the point-of-care using isothermal DNAbased assays in a portable, de-gas microfluidic diagnostic assay platform # Lars D. Renner 1,2,
More informationUltrashort self-assembling peptidomimetic nanomaterials target resistant pathogenic infections
Ultrashort self-assembling peptidomimetic nanomaterials target resistant pathogenic infections Laverty, G. (2015). Ultrashort self-assembling peptidomimetic nanomaterials target resistant pathogenic infections.
More informationIntroducing. Wound Dressing. Incorporated with
q Introducing Wound Dressing Incorporated with Exciton s exsalt SD7 Wound Dressing utilizes the Company s patented silver oxysalts technology: Broad spectrum antimicrobial action Excellent biocompatibility
More informationGovernance and finance recommendations
DRIVE-AB DRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE Governance and finance recommendations Christine Årdal (Norwegian Institute of Public Health) for the DRIVE-AB consortium What? How
More informationDevelopment of Potent Type III Secretion System Inhibitors
Development of Potent Type III Secretion System Inhibitors (OTT ID 1112 and 1200) Inventors: Ching-Hong Yang, Ph.D., Xin Chen, Ph.D., & Eric Toone, Ph.D. Department of Biological Sciences, UW-Milwaukee
More informationBT-201: INVESTIGATION OF THE SPIDER WEB FOR ANTIBACTERIAL ACTIVITY
BT-201: INVESTIGATION OF THE SPIDER WEB FOR ANTIBACTERIAL ACTIVITY Mohamed E. S. Mirghani 1*, N. A. Kabbashi 1, F. A. Elfaki 2 and M. Z. Fahmi B. Zulkifli 1 1 Department of Biotechnology Engineering, Kulliyyah
More informationND4BB Topic 3: Discovery and development of new drugs combatting Gram-negative infections
ND4BB Topic 3: Discovery and development of new drugs combatting Gram-negative infections Rob Stavenger for EFPIA partners (AstraZeneca, Basilea, GlaxoSmithKline, & Sanofi) 17 December 2012 Antibiotic
More informationShionogi Presents Results of the First Clinical Efficacy Trial and In Vitro Data on Cefiderocol (S ), a Siderophore Cephalosporin
Shionogi Presents Results of the First Clinical Efficacy Trial and In Vitro Data on Cefiderocol (S-649266), a Siderophore Cephalosporin Osaka, Japan, April 22, 2017 - Shionogi & Co., Ltd. today announced
More informationDeveloping Bacteriophage Therapies for Patients with Antibiotic-Resistant Infections
Developing Bacteriophage Therapies for Patients with Antibiotic-Resistant Infections June 6, 2017 NYSE MKT: APHB Safe Harbor Statement This presentation contains forward-looking statements that involve
More informationSupplementary data Table 1
Supplementary data Table 1 Amino acid sequences, antimicrobial effects, and hydrophobicity of peptides analysed. For determination of antimicrobial activities, S. aureus ATCC 29213, E. coli ATCC 25922
More informationThorny topics related to CRE control
Thorny topics related to CRE control Michael Lin, MD MPH Rush University Medical Center Chicago CDC Prevention Epicenter 19 th Annual Chicago Infection Control Conference May 30, 2014 Disclosures I have
More information10/2/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics
Control of Microbial Growth Disinfectants and Antiseptics 1 Method Three approaches for the control of microbial growth Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical
More informationSection B and C. Volume-21. Contents 12. APPLIED BIOLOGY. Life Sciences For NET & SLET Exams Of UGC-CSIR. *Mudra*
Section B and C Volume-21 Contents 12. APPLIED BIOLOGY A. MICROBIAL FERMENTATION AND PRODUCTION OF SMALL AND MACRO MOLECULES 1 B. APPLICATIONS OF IMMUNOLOGICAL PRINCIPLES 47 TISSUE AND CELL CULTURE METHODS
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: W81XWH-12-2-0067 TITLE: The Potential Application and Risks Associated With the Use of Predatory Bacteria as a Biocontrol Agent Against Wound Infections PRINCIPAL INVESTIGATOR: Daniel
More informationSYNTHETIC ANTIBIOTIC PEPTIDES DATABASE
Protein and Peptide Letters, Vol. 9, No. 1, pp. 53-57, 2002 Bentham Science Publishers Ltd. 0929-8665/02 $ 35.00 +.00 SYNTHETIC ANTIBIOTIC PEPTIDES DATABASE David Wade 1 * and Jukka Englund 2 1 Peptide
More information01/08/2018. Control of Microbial Growth. Methods. Terminology. Disinfectants and Antiseptics. Three approaches. Cleaning. Chemical.
Control of Microbial Growth Disinfectants and Antiseptics 1 Methods 2 Three approaches Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical elimination Cleaning Filtration
More informationInternational Journal of Antimicrobial Agents 29 (2007) Short communication
International Journal of Antimicrobial Agents 29 (2007) 317 321 Short communication Activities of four frog skin-derived antimicrobial peptides (temporin-1dra, temporin-1va and the melittin-related peptides
More informationChallenges of Antimicrobial Testing: Perspectives from the Field
Challenges of Antimicrobial Testing: Perspectives from the Field Lou Protonentis Textile Chemist Global Technical Director Noble Biomaterials Inc. Robert (Bob) A. Monticello, Ph.D. Textile Microbiologist
More information55 Industrial Park Road Boothbay, ME USA
Introduction Increasing the level of sanitation and sterility of health-care environments is critical in reducing the transmission of health-care associated infections. The Center for Disease Control estimates
More informationFor in vitro killing assays with lysed cells, neutrophils were sonicated using a 550 Sonic
Supplemental Information Cell Host & Microbe, Volume 8 Statins Enhance Formation of Phagocyte Extracellular Traps Ohn A. Chow, Maren von Köckritz-Blickwede, A. Taylor Bright, Mary E. Hensler, Annelies
More information3.0. Materials and methods
63 3.0. Materials and methods 3.1. Plant materials and preparation of extracts Salacia oblonga plants were collected from Western Ghats, Karnataka, India. S. oblonga (RRCBI 7881) authentication was done
More informationAntibiotic Susceptibility Testing (ABST/AST)
Antibiotic Susceptibility Testing (ABST/AST) Goal Offer guidance to physicians in selecting effective antibacterial therapy for a pathogen in a specific body site. Performed on bacteria isolated from clinical
More informationGuidelines for Laboratory Verification of Performance of the FilmArray Blood Culture Identification (BCID) Panel
Guidelines for Laboratory Verification of Performance of the FilmArray Blood Culture Identification (BCID) Panel Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes
More informationProtocols for Laboratory Verification of Performance of the FilmArray Blood Culture Identification (BCID) Panel
Protocols for Laboratory Verification of Performance of the FilmArray Blood Culture Identification (BCID) Panel Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes
More informationHow antimicrobial agents work
Physical and Chemical Control of Microbes Physical Agents heat or radiation Chemical Agents disinfectants or antiseptics Important Terms 1. Sterilization process of killing all viable microbes 2. Bactericide
More informationChemoinformatic Tools for the Hit Discovery Process
Chemoinformatic Tools for the Hit Discovery Process GmbH Björn Windshügel May 29 2013 ESP in a Nutshell Established in 2007 Service provider for academics High-throughput screening High-content screening
More information2120 Lab. Week 11. Experiments 13,14,21. Kirby Bauer, TDT, Chemicals
2120 Lab Week 11 Experiments 13,14,21 Kirby Bauer, TDT, Chemicals Controlling Microorganisms Decontamination: Physical, chemical, and mechanical methods to destroy or reduce undesirable microbes in a given
More informationNEW DRUG FORMULATIONS TO BOOST FIGHT AGAINST RESPIRATORY ILLNESSES AND ANTIBIOTIC-RESISTANT SUPERBUGS
MEDIA RELEASE FOR IMMEDIATE RELEASE 15 September 2014 NEW DRUG FORMULATIONS TO BOOST FIGHT AGAINST RESPIRATORY ILLNESSES AND ANTIBIOTIC-RESISTANT SUPERBUGS A team from A*STAR s Institute of Chemical and
More informationANTIMICROBIAL FLOORING FACTS...
ANTIMICROBIAL FLOORING FACTS... For the Food and Beverage Industry HACCP CERTIFIED FLOORING www.flowcreteaustralia.com.au Minimising the risk of contamination despite an intense working environment is
More informationAntibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
SUPPLEMENTARY MATERIALS Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens Shankar Thangamani 1, Haroon Mohammad 1, Mostafa F.N. Abushahba 1,2,
More informationBEAM Alliance urges G20 support to fight deadly superbugs
Press Release BEAM Alliance urges G20 support to fight deadly superbugs At the Hamburg G20 summit, political leaders will speak about a growing global health threat - antibiotic resistance - which causes
More informationPatentability/Literature Research
Patentability/Literature Research The probiotic-based solution to combat cholera as presented here comprises of two major innovative components: (1) the metabolite-dependent pathogen inhibition by a probiotic
More information6/28/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics
Control of Microbial Growth Disinfectants and Antiseptics 1 Method Three approaches for the control of microbial growth Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical
More informationEvaluation of a Novel Non-Sterile Glove Dispensing System Uyen Nguyen
Evaluation of a Novel Non-Sterile Glove Dispensing System Uyen Nguyen Edited by: Michael Diamond Reviewed by: Andrew Duong Disclaimer: The author of this report and declare no conflict of interest with
More informationDeveloping Novel Antibacterials to Treat Multi-drug Resistant Gram-negative Bacterial Infections. 13 th Needham Healthcare Conference April 8, 2014
Developing Novel Antibacterials to Treat Multi-drug Resistant Gram-negative Bacterial Infections 13 th Needham Healthcare Conference April 8, 2014 Forward Looking Statements Forward-Looking Statements
More informationProtocols for Laboratory Verification of Performance of the BioFire FilmArray Blood Culture Identification (BCID) Panel
Protocols for Laboratory Verification of Performance of the BioFire FilmArray Blood Culture Identification (BCID) Panel A Laboratory Protocol for Use with Live s Purpose The Clinical Laboratory Improvement
More informationCDC Antibiotic Resistance Laboratory Network- Southeast Region. Nailah Smith, DVM, MPH, Epidemiologist
CDC Antibiotic Resistance Laboratory Network- Southeast Region Nailah Smith, DVM, MPH, Epidemiologist Overview ARLN Introduction Southeast Regional Laboratory Overview ARLN Alert Values Isolate flow CRE
More informationPROJECT TITLE DESCRIPTION CHIEF INVESTIGATOR DETAILS
PROJECT TITLE DESCRIPTION CHIEF INVESTIGATOR DETAILS Characterisation of the function of the essential transcription elongation factor NusA NusA is a highly conserved transcription elongation factor from
More informationIsolation and Characterization of Two Antibiotic-Producing Bacteria
Isolation and Characterization of Two Antibiotic-Producing Bacteria Madeline Gibson Abstract The discovery of antibiotics with novel mechanisms has plateaued in the last twenty years. As antibiotics are
More informationBringing True Novelty to the Anti-Infective Space
Bringing True Novelty to the Anti-Infective Space New Class of Antibacterials Based on a Unique Mechanism of Action Dr Dawn Firmin SMi s 17 th Annual Conference on Superbugs & Superdrugs March 2015 1 Contents
More informationOpen-access antimicrobial drug discovery BIO 2016
Open-access antimicrobial drug discovery BIO 2016 Matt Cooper Institute for Molecular Bioscience The University of Queensland Antibiotics are not drug-like Don t obey the rules Rule of Five Molecular Weight:
More informationOpen-access antimicrobial drug discovery BIO 2016
Open-access antimicrobial drug discovery BIO 2016 Matt Cooper Institute for Molecular Bioscience The University of Queensland Antibiotics are not drug-like Don t obey the rules Rule of Five Molecular Weight:
More informationAcanthamoeba and bacteria produce antimicrobials to target their counterpart
Iqbal et al. Parasites & Vectors 2014, 7:56 SHORT REPORT Open Access Acanthamoeba and bacteria produce antimicrobials to target their counterpart Junaid Iqbal, Ruqaiyyah Siddiqui and Naveed Ahmed Khan
More informationNasdaq: AKAO. Cowen Health Care Conference March 3, 2015
Nasdaq: AKAO Cowen Health Care Conference March 3, 2015 Forward Looking Statements Forward-Looking Statements This presentation contains forward-looking statements. All statements other than statements
More informationBacterial Contamination in Platelets Canadian Blood Services - Update. Sandra Ramirez-Arcos ISBT TTID WP Meeting June 17, 2017
Bacterial Contamination in Platelets Canadian Blood Services - Update Sandra Ramirez-Arcos ISBT TTID WP Meeting June 17, 2017 Bacterial testing automated BacT/ALERT 3D culture system Routine Platelet Screening
More informationThe best solution for surface disinfection in the following environments:
Ecological and safe to use Always consistent results Penetrates even biofilm Nonionizing Reduces the amount of airborne particles Suitable for automatic and remote control chemicalfree UVfree Suitable
More informationMicrobial allies in Disease Detection and Treatment. Journal club presentation Vijay Chandrasekar
Microbial allies in Disease Detection and Treatment Journal club presentation Vijay Chandrasekar 16.06.2015 Our inner ecosystem Over 100 TRILLION bacteria (including perhaps a billion or more E.Coli) Individuals
More informationCombatting AMR: diagnostics
Combatting AMR: diagnostics Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright Gonorrhoea: a paradigm for better diagnostics International
More informationSelenium nanoparticles and their utilization in scaffolds. Prof. RNDr. Vojtech Adam, Ph.D. Mgr. Dagmar Hegerova, Ph.D. Mendel University in Brno
Selenium nanoparticles and their utilization in scaffolds Prof. RNDr. Vojtech Adam, Ph.D. Mgr. Dagmar Hegerova, Ph.D. Mendel University in Brno 2 Content 1. Nanoparticles silver, selenium Staphylococcus
More informationWP8 Branka Bedenic, University Hospital Zagreb, Croatia Valentino D Onofrio, Jessa hospital and Hasselt University, Belgium
WP8 Branka Bedenic, University Hospital Zagreb, Croatia Valentino D Onofrio, Jessa hospital and Hasselt University, Belgium Inge Gyssens, Jessa hospital and Hasselt University and Radboud University Medical
More informationComparison of the speed of kill of pathogenic bacteria using ACTICOAT and AQUACEL Ag analysed using Confocal Laser Scanning Microscopy
Smith & Nephew Wound Management Data on file report - 0505004 May 2005 Comparison of the speed of kill of pathogenic bacteria using ACTICOAT and AQUACEL Ag analysed using Confocal Laser Scanning Microscopy
More informationRoche. New York City 7 December 2016
Roche Andrew C. Chan, M.D. Ph.D. Senior Vice President, Research Biology of Genentech Research and Early Development (gred) New York City 7 December 2016 This presentation contains certain forward-looking
More informationGenetika Mikroorganisme. dr. Agus Eka Darwinata, Ph.D
Genetika Mikroorganisme dr. Agus Eka Darwinata, Ph.D Gene and Genome The Central Dogma Mutation TOPIC Polimerase Chain Reaction Mechanism of Antimicrobioal Resistance Gene and Genome Genom adalah keseluruhan
More informationJKMU. Antimicrobial Activity of Combined Extracts of Trachyspermum, Thymus and Pistachio against Some Pathogenic Bacteria ARTICLE INFO.
JKMU Journal of Kerman University of Medical Sciences, 2018; 25 (2): 153-163 Antimicrobial Activity of Combined Extracts of Trachyspermum, Thymus and Pistachio against Some Pathogenic Bacteria Fatemeh
More informationGood Science. Benefit to Society
Good Science Benefit to Society Human genes claimed in granted U.S. patents Jensen and Murray, Science 310:239-240 (14 Oct. 2005) Specifically, this map is based on a BLAST homology search linking nucleotide
More informationDivision of Dockets Management (HFA 305) U.S. Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852
May 24, 2012 Division of Dockets Management (HFA 305) U.S. Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852 Re: Comments on Docket #FDA- 2012 D 0148; Draft Guidance for Industry
More informationGame plan. Lecture. Lab. Antibiotics Antibiotic resistance Gene transfer Transformation Transduction Conjugation
Game plan Lecture Antibiotics Antibiotic resistance Gene transfer Transformation Transduction Conjugation Lab Review temp and UV labs Growth control: alcohol, antiseptics and antibiotics Pre-lab Transformation
More informationOral vaccines to protect patients against Clostridium difficile infection
Oral vaccines to protect patients against Clostridium difficile infection Jonathan Kearsey: Leads To Development Antibiotics and their alternatives-fixing and feeding the pipeline Project number: 601810
More informationIsolation of Host Specific Bacteriophages against Salmonella and Methicillin Resistant Staphylococcus aureus (MRSA) From Hospital Waste Water
IOSR Journal of Biotechnology and Biochemistry (IOSR-JBB) ISSN: 2455-264X, Volume 4, Issue 4 (Jul. Aug. 2018), PP 11-15 www.iosrjournals.org Isolation of Host Specific Bacteriophages against Salmonella
More informationFORWARD LOOKING STATEMENTS
Jefferies 2014 Healthcare Conference November 19, 2014 FORWARD LOOKING STATEMENTS This presentation contains forward looking statements. Any statements contained herein which do not describe historical
More information